DO NOT PRESCRIBE (DNP)6: NICE TA378 for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma previously treated with chemotherapy. (decision date - February 2016)
DO NOT PRESCRIBE (DNP)6: NICE TA403 for previously treated locally advanced or metastatic non-small cell lung cancer. (Decision date - September 2016)
DO NOT PRESCRIBE (DNP)6: NICE TA609 - treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal) (Decision date - November 2019)
DO NOT PRESCRIBE (DNP)6: NICE TA635 - ramucirumab with erlotinib for untreated EGFR-positive metastatic NSCLC (terminated appraisal) (Decision date - July 2020)
